Go Pro

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GOCO

GoHealth (GOCO) Stock Price, News & Analysis

GoHealth logo

About GoHealth Stock (NASDAQ:GOCO)

Key Stats

Today's Range
$0.29
$0.33
50-Day Range
$0.29
$0.99
52-Week Range
$0.28
$7.12
Volume
2.70 million shs
Average Volume
916,731 shs
Market Capitalization
$8.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Hold

Company Overview

GoHealth, Inc. is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey. GoHealth’s offerings span Affordable Care Act (ACA) plans, short-term health coverage and specialty products, with a strong emphasis on Medicare solutions. Its platform incorporates compliance features and digital underwriting capabilities that streamline application processing and reduce administrative overhead for partner carriers.

Founded in 2009 and headquartered in Chicago, Illinois, GoHealth has grown to serve consumers across all 50 states. The company maintains strategic partnerships with major insurance providers—including UnitedHealthcare, Humana, Aetna, Cigna and Blue Cross Blue Shield entities—to deliver a broad spectrum of plan options. By continuously enhancing its technology stack and expanding carrier integrations, GoHealth has positioned itself as a leading intermediary in the U.S. health insurance market.

Under the leadership of Chief Executive Officer Nick Drilias, GoHealth has pursued both organic innovation and targeted acquisitions to reinforce its digital distribution capabilities. The executive team comprises seasoned professionals from the insurance and technology sectors, supporting the company’s mission to simplify access to health coverage. With a focus on customer experience, regulatory compliance and scalable platform solutions, GoHealth continues to evolve its services to meet changing market needs and consumer expectations.

AI Generated. May Contain Errors.

GoHealth Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
29th Percentile Overall Score

GOCO MarketRank™: 

GoHealth scored higher than 29% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    GoHealth has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 1 strong buy rating, no buy ratings, 3 hold ratings, and 1 sell rating.

  • Upside Potential

    GoHealth has a consensus price target of $5.00, representing about 1,577.9% upside from its current price of $0.30.

  • Amount of Analyst Coverage

    GoHealth has received no research coverage in the past 90 days.

  • Read more about GoHealth's stock forecast and price target.
  • Earnings Growth

    Earnings for GoHealth are expected to grow in the coming year, from ($9.19) to ($5.53) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of GoHealth is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of GoHealth is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about GoHealth's valuation and earnings.
  • Short Interest

    There is no current short interest data available for GOCO.
  • Dividend Yield

    GoHealth does not currently pay a dividend.

  • Dividend Growth

    GoHealth does not have a long track record of dividend growth.

  • MarketBeat Follows

    1 people have added GoHealth to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GoHealth insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    29.12% of the stock of GoHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    24.21% of the stock of GoHealth is held by institutions.

  • Read more about GoHealth's insider trading history.
Receive GOCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GoHealth and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GOCO Stock News Headlines

GOCOQ Share News Today
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
GoHealth delays quarterly filing amid restructuring talks
See More Headlines

GOCO Stock Analysis - Frequently Asked Questions

GoHealth, Inc. (NASDAQ:GOCO) posted its earnings results on Monday, May, 18th. The company reported ($2.36) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.40) by $0.04. The firm earned $11.91 million during the quarter, compared to analyst estimates of $16.90 million. GoHealth had a negative net margin of 189.73% and a negative trailing twelve-month return on equity of 402.70%.

GoHealth (GOCO) raised $826 million in an initial public offering (IPO) on Wednesday, July 15th 2020. The company issued 43,500,000 shares at a price of $18.00-$20.00 per share. Goldman Sachs, BofA Securities and Morgan Stanley acted as the underwriters for the IPO and Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair, Cantor, SunTrust Robinson Humphrey and Loop Capital Markets were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that GoHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Invesco QQQ (QQQ), Tesla (TSLA), Netflix (NFLX) and Intel (INTC).

Company Calendar

Last Earnings
5/18/2026
Today
8/02/2026
Next Earnings (Estimated)
8/06/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Finance
Industry
Insurance
Sub-Industry
Multi-line Insurance
Current Symbol
NASDAQ:GOCO
CIK
1808220
Fax
N/A
Employees
2,261
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$5.00
Potential Upside/Downside
+1,577.9%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($20.29)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$257.13 million
Net Margins
-189.73%
Pretax Margin
-365.10%
Return on Equity
-402.70%
Return on Assets
-7.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.03
Quick Ratio
2.03

Sales & Book Value

Annual Sales
$152.79 million
Price / Sales
0.06
Cash Flow
$1.24 per share
Price / Cash Flow
0.24
Book Value
($2.16) per share
Price / Book
-0.14

Miscellaneous

Outstanding Shares
28,846,000
Free Float
20,446,000
Market Cap
$8.60 million
Optionable
Not Optionable
Beta
1.19

Social Links

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:GOCO) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners